Hermetica Superfood Encyclopedia
The Short Answer
Jaboticaba fruit contains novel depsides (jaboticabin and 2-O-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxyphenylacetic acid), anthocyanins (cyanidin-3-glucoside, delphinidin-3-glucoside), ellagitannins, and flavonoids that exert antioxidant effects via radical scavenging and suppress IL-8 cytokine production through phenolic-mediated inflammatory pathway inhibition. In preclinical in vitro models, jaboticabin demonstrated antiradical activity with an IC50 of 51.4 μM in the DPPH assay and cytotoxicity against HT29 colon cancer cells at an IC50 of 65 μM, while a related depside showed IC50 of 30 μM against HCT116 colon cancer cells, though no human clinical trials have yet confirmed these effects.
CategoryBerry
GroupAmazonian
Evidence LevelPreliminary
Primary Keywordjaboticaba benefits
Jaboticaba — botanical close-up
Health Benefits
**Antioxidant Activity**
Jaboticabin and related depsides scavenge free radicals with IC50 values of 51.4 μM and 61.8 μM respectively in DPPH assays, while cyanidin-3-glucoside and delphinidin-3-glucoside contribute additional anthocyanin-driven oxidative protection.
**Anti-Inflammatory Effects**
Novel depsides isolated from jaboticaba fruit inhibit IL-8 chemokine production in cell-based models, including under cigarette smoke-induced oxidative stress conditions, suggesting suppression of NF-κB-dependent inflammatory signaling.
**Potential Anticancer Properties**
Jaboticabin exhibits cytotoxicity against HT29 human colon adenocarcinoma cells (IC50 65 μM), and the structurally related depside shows IC50 of 30 μM in HCT116 colon cancer cells, likely through apoptosis induction mediated by phenolic-quinone redox cycling.
**Antimicrobial Activity**
Flavonoids, ellagitannins (iso-oenothein C, oenothein C), and tannins present in the peel and seed residues exhibit broad antimicrobial properties in preliminary studies, interfering with microbial membrane integrity and enzyme function.
**Anti-Hyperglycemic Potential**
Polyphenol-rich fractions from jaboticaba seeds and peels have demonstrated inhibition of alpha-glucosidase and alpha-amylase activity in preclinical models, supporting blood glucose modulation through delayed carbohydrate digestion.
**Antihypertensive Effects**
Ellagitannins and flavonoids from jaboticaba residues show ACE-inhibitory activity in preclinical assays, suggesting a mechanism relevant to blood pressure regulation through the renin-angiotensin system.
**DNA Protective and Antimutagenic Activity**
Tannin and flavonoid fractions from jaboticaba seeds and peels have shown antimutagenic potential in Ames test models, likely through direct interaction with reactive electrophiles and modulation of Phase II detoxification enzymes.
Origin & History
Natural habitat
Myrciaria cauliflora, commonly known as jaboticaba, is native to the Atlantic Forest region of Brazil, particularly the states of Minas Gerais, São Paulo, and Rio de Janeiro, where it grows as a slow-maturing tree in subtropical and tropical climates. The tree is distinctive for its cauliflorous fruiting pattern, bearing dark purple to black grape-like berries directly on the trunk and main branches rather than on terminal shoots. Traditionally cultivated in home gardens and small orchards across Brazil, it has been spread to other parts of South America, the Caribbean, and subtropical regions worldwide, though commercial-scale cultivation remains limited.
“Jaboticaba has been cultivated and consumed in Brazil for centuries, with Indigenous peoples of the Atlantic Forest and cerrado regions incorporating the fruit into their diet long before European colonization, valuing it for its nutritional richness and as a source of fermented beverages. The fruit holds significant cultural importance in Brazilian culinary tradition, where it is made into artisanal wines, liqueurs, jellies, and caipirinhas, and continues to be associated with regional identity in Minas Gerais and surrounding states. Traditional medicinal applications attributed to jaboticaba in Brazilian folk medicine include the use of sun-dried fruit skins as a remedy for chronic diarrhea, dysentery, and tonsillitis, and the astringent tannin-rich peel has historically been employed as an anti-inflammatory oral rinse. Modern phytochemical research has largely validated the phenolic richness that underlies these traditional applications, though the mechanistic basis was not understood by early practitioners who relied on empirical observation and oral transmission of knowledge.”Traditional Medicine
Scientific Research
The current evidence base for Myrciaria cauliflora consists entirely of in vitro preclinical studies and phytochemical characterization research, with no published human clinical trials identified in the peer-reviewed literature as of the available search data. Key studies have employed LC-MS/MS-based profiling to identify 63 phenolic compounds across fruit fractions, and isolated bioassay-guided fractionation has yielded jaboticabin and a structurally related depside with quantified IC50 values in DPPH radical scavenging (51.4 μM and 61.8 μM) and cancer cell cytotoxicity (HT29 IC50 65 μM; HCT116 IC50 30 μM) assays. Research on seed and peel residues highlights their value as bioactive material sources for antimutagenic, antimicrobial, anti-hyperglycemic, and antihypertensive activities, though these findings are drawn from heterogeneous experimental models using variable extraction solvents and methodologies that limit direct cross-study comparison. The overall evidence quality is low by clinical standards, and translation of preclinical findings to therapeutic applications in humans requires dose-escalation studies, pharmacokinetic characterization, and controlled intervention trials that have not yet been conducted.
Preparation & Dosage
Traditional preparation
**Whole Fresh Fruit**
Traditionally consumed as a fresh fruit in Brazil; no established therapeutic dose; nutritional intake is food-level and considered safe as part of a normal diet.
**Juice and Infusions**
Prepared by pressing the whole fruit or steeping dried powder in water; bioactive phenolic concentrations decline significantly after 150–180 minutes of infusion, suggesting fresh preparation is preferable for maximum phytochemical content.
**Fermented Products (Wine/Liqueur)**
Traditional preparations involve fermenting whole fruit or peel/seed residues; phenolic profiles differ significantly from fresh fruit due to microbial and oxidative transformation during fermentation.
**Dried Powder (Peel/Seed Residues)**
Research models use aqueous or methanolic extracts of dried peels and seeds standardized to total phenolic content; no commercial standardization percentage has been established for supplements.
**Experimental Extracts**
Laboratory studies use 70% ethanol or methanol extracts for bioactive isolation; no commercial supplement form has defined dosing or bioavailability data validated in humans.
**Timing Notes**
Traditional consumption occurs as a fresh seasonal fruit; no clinical timing guidance exists for supplemental forms pending human pharmacokinetic studies.
Nutritional Profile
Jaboticaba fruit is composed primarily of water (approximately 84–88% fresh weight) with modest carbohydrate content (approximately 8–13 g/100 g), low protein (0.06–0.1 g/100 g), and minimal fat. Micronutrient content includes vitamin C (approximately 20–25 mg/100 g), potassium, calcium, phosphorus, and iron at levels typical of tropical fruits, contributing meaningfully to dietary micronutrient intake when consumed in quantity. The dominant phytochemical fraction consists of anthocyanins concentrated in the dark purple skin, with cyanidin-3-glucoside as the primary anthocyanin and delphinidin-3-glucoside as a chemotaxonomic marker for M. cauliflora; ellagitannins (iso-oenothein C, oenothein C) are prominent in seeds and peels, while flavonoids constitute approximately 40% of identified phenolic compounds across whole fruit fractions. Bioavailability of anthocyanins is generally low (estimated <5% systemic absorption for intact glycosides in humans from other fruit sources), and ellagitannins must be microbiota-converted to urolithins for systemic activity, meaning individual gut microbiome composition is a major determinant of realized biological effect from jaboticaba consumption.
How It Works
Mechanism of Action
The novel depsides jaboticabin and 2-O-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxyphenylacetic acid act as direct radical scavengers through hydrogen atom transfer and single-electron transfer mechanisms, as quantified in DPPH assays, while simultaneously suppressing IL-8 chemokine secretion in inflammatory cell models, likely through inhibition of NF-κB transcriptional activation or MAPK signaling cascades upstream of cytokine gene expression. Anthocyanins cyanidin-3-glucoside and delphinidin-3-glucoside contribute to antioxidant defense by chelating transition metals and quenching reactive oxygen species, and may modulate Nrf2-ARE pathway activation to upregulate endogenous antioxidant enzymes such as superoxide dismutase and glutathione peroxidase. Ellagitannins including iso-oenothein C and oenothein C are hydrolyzed in the gut to ellagic acid and subsequently converted by colonic microbiota to urolithins, bioavailable metabolites that further inhibit pro-inflammatory enzymes including COX-2 and 5-LOX. The cytotoxic activity of jaboticabin against colon cancer cell lines at micromolar concentrations suggests engagement of apoptotic pathways, potentially involving mitochondrial membrane depolarization and caspase activation, though specific receptor-level targets remain to be elucidated in dedicated mechanistic studies.
Clinical Evidence
No human clinical trials evaluating Myrciaria cauliflora or its isolated constituents for any health outcome have been reported in available literature. All mechanistic and efficacy data derive from cell-based in vitro experiments using cancer cell lines (HT29, HCT116), cytokine secretion assays, and biochemical radical-scavenging models, none of which can establish clinical efficacy or therapeutic dosing in humans. Preclinical outcomes, while showing quantifiable effects at micromolar concentrations for antioxidant and cytotoxic endpoints, cannot be extrapolated to predict human response without bioavailability and pharmacokinetic data. Confidence in any specific clinical benefit remains very low, and jaboticaba should currently be regarded as a nutritionally valuable food with promising but unvalidated medicinal potential pending clinical investigation.
Safety & Interactions
No adverse effects, drug interactions, or contraindications have been formally documented for Myrciaria cauliflora fruit or its extracts in human subjects, as no clinical safety studies have been conducted to date. The preclinical cytotoxicity data (IC50 30–65 μM for cancer cell lines) indicates that isolated depsides exhibit biological activity at concentrations that may not be achievable through normal dietary consumption, but the safety margin at supplemental extract doses in humans is undefined. Due to the high tannin content in peel and seed preparations, theoretical concerns include interference with iron absorption and potential interactions with medications that bind phenolic compounds, such as iron supplements, certain antibiotics, and drugs with narrow therapeutic windows metabolized by CYP450 enzymes, though these interactions are speculative in the absence of specific interaction studies. Pregnancy and lactation safety is unstudied; consumption as a whole food in typical dietary amounts is presumed low-risk based on long-term traditional use, but concentrated extracts or high-dose supplements should be avoided in vulnerable populations until safety data are available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Myrciaria caulifloraBrazilian grapetreejabuticabajaboticabeiraPlinia cauliflora
Frequently Asked Questions
What are the main health benefits of jaboticaba?
Jaboticaba fruit contains novel depsides (jaboticabin), anthocyanins (cyanidin-3-glucoside, delphinidin-3-glucoside), and ellagitannins that demonstrate antioxidant, anti-inflammatory, antimicrobial, and potential anticancer properties in preclinical cell studies. Jaboticabin showed DPPH radical scavenging with IC50 of 51.4 μM and cytotoxicity against HT29 colon cancer cells at IC50 of 65 μM, and depsides suppressed IL-8 chemokine production in inflammatory models, though no human clinical trials have confirmed these benefits to date.
Is jaboticaba safe to eat or take as a supplement?
Consuming jaboticaba as a whole fresh fruit or in traditional preparations such as juice, wine, or jelly is considered low-risk based on centuries of dietary use in Brazil, with no documented adverse effects in the available literature. However, concentrated peel or seed extracts have not undergone formal human safety studies, and the high tannin content may theoretically inhibit iron absorption or interact with certain medications; pregnant or breastfeeding individuals and those on medications should consult a healthcare provider before using concentrated forms.
How do you eat or prepare jaboticaba?
Jaboticaba is most commonly eaten fresh by squeezing the grape-like fruit directly into the mouth and discarding the thick skin, though the skin is edible and contains the highest concentration of anthocyanins and tannins. Traditional Brazilian preparations include juices, artisanal wines, liqueurs, jams, and dried powder infusions; research notes that phenolic content in liquid infusions declines significantly after 150–180 minutes, so fresh preparation is preferable for maximum bioactive retention.
What is jaboticabin and why is it significant?
Jaboticabin is a novel depside compound identified specifically in Myrciaria cauliflora fruit, representing a newly characterized class of phenolic bioactive not previously documented in this species. It demonstrated quantifiable antiradical activity (DPPH IC50 51.4 μM) and selective cytotoxicity against HT29 human colon cancer cells (IC50 65 μM) in in vitro studies, making it a pharmacologically interesting lead compound, though its bioavailability, in vivo activity, and safety in humans have not yet been studied.
Does jaboticaba have any anti-cancer properties?
Preclinical in vitro studies show that jaboticabin inhibits HT29 colon adenocarcinoma cell growth at IC50 65 μM, while a structurally related depside shows IC50 of 30 μM in HCT116 colon cancer cells, suggesting cytotoxic activity likely mediated through apoptosis induction and phenolic-quinone redox mechanisms. These findings are strictly laboratory-based and cannot be interpreted as evidence that jaboticaba treats or prevents cancer in humans; no clinical trials have investigated jaboticaba for any oncological indication.
What is the difference between fresh jaboticaba fruit and jaboticaba extract supplements?
Fresh jaboticaba fruit contains the full spectrum of bioactive compounds including jaboticabin, anthocyanins, and depsides in their natural matrix, while extracts concentrate specific compounds but may lose some synergistic effects. Extract supplements offer standardized dosing and longer shelf stability, making them more practical for consistent supplementation, whereas fresh fruit provides whole-food nutrition with additional fiber and nutrients. Clinical research has primarily focused on isolated compounds and extracts, so whole fruit efficacy data is more limited.
Can jaboticaba supplementation interact with blood pressure or anti-inflammatory medications?
Jaboticaba's depsides and anthocyanins exhibit anti-inflammatory and antioxidant effects that could theoretically potentiate medications targeting similar pathways, particularly antihypertensive or immunosuppressive drugs. While no major adverse interactions have been formally documented, the potent IL-8 inhibition demonstrated in cell studies suggests caution when combining jaboticaba supplements with prescription anti-inflammatory agents. Individuals taking medications should consult a healthcare provider before adding jaboticaba supplementation to assess individual risk.
What does current research reveal about jaboticaba's effectiveness for inflammatory conditions?
In vitro studies show that novel depsides isolated from jaboticaba effectively inhibit IL-8 chemokine production in cell models, suggesting potential anti-inflammatory utility for conditions driven by IL-8 dysregulation. However, most evidence remains at the cellular or animal model stage, with limited human clinical trials specifically evaluating jaboticaba for inflammatory diseases. The antioxidant capacity demonstrated through DPPH assays (IC50 values of 51.4–61.8 μM) supports its free radical-scavenging potential, but translating this to clinical outcomes requires further human research.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w jaboticaba-myrciaria-cauliflora curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
